CAS 129580-63-8: Satraplatin
(World's Largest Pharmaceutical Supplier)

Satraplatin, CAS 129580-63-8

Satraplatin, CAS 129580-63-8, Stock 742g, Assay 99.39%, White powder, Water 0.21%, Single Impurity 0.40%.

Satraplatin

Satraplatin, also known as JM216 and BMS182751, is a platinum compound that is currently under investigation as one treatment of patients with advanced prostate cancer who have failed previous chemotherapy. It has not yet received approval from the U.S. Food and Drug Administration. First mentioned in the medical literature in 1993, satraplatin is the first orally active platinum-based chemotherapeutic drug; other available platinum analogues—cisplatin, carboplatin, and oxaliplatin—must be given intravenously.

Product Details:

Name: Satraplatin

CAS#: 129580-63-8

Chemical Formula: C10H22Cl2N2O4Pt

Exact Mass: 499.06044

Molecular Weight: 500.28

Elemental Analysis: C, 24.01; H, 4.43; Cl, 14.17; N, 5.60; O, 12.79; Pt, 38.99

Specification:

Synonym: BMS182751; BMS 182751; BMS-182751; JM 216; JM-216; JM216; Satraplatin

IUPAC/Chemical Name: (OC-6-43)-bis(acetato)amminedichloro(cyclohexylamine)platinum

InChi Key: CKNPWBAXEKSCRG-UHFFFAOYSA-J

InChi Code: InChI=1S/C6H13N.2C2H4O2.2ClH.H3N.Pt/c7-6-4-2-1-3-5-6;2*1-2(3)4;;;;/h6H,1-5,7H2;2*1H3,(H,3,4);2*1H;1H3;/q;;;;;;+4/p-4

SMILES Code: CC(O[Pt]([NH2]C1CCCCC1)(Cl)(Cl)([NH3])OC(C)=O)=O

Appearance: Solid powder

Purity: >99% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO, not soluble in water.

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Certifications: